Atrial arrhythmias associated with anti-tumor drugs in patients with malignant tumors and type 2 diabetes mellitus
{{output}}
Objective: Patients with malignancies and type 2 diabetes mellitus (T2DM) face heightened risks of cardiotoxicity from antitumor therapies, yet the interplay between diabetes, antitumor drugs, and atrial arrhythmias remains under... ...
